Biotech, Stem Cells, Life Sciences

CellCyte Genetics Shuts Down

Luke Timmerman 12/24/08

CellCyte Genetics, the Bothell, WA-based stem cell research company, has shut down. The company said it had a little more than $5,700 in cash at the end of September, according to its quarterly filing with the Securities and Exchange Commission, as reported by The Seattle Times. “We presently do not have sufficient cash to fund our operations, and have curtailed substantially all activities,” the company said in the filing.

Luke Timmerman is the National Biotechnology Editor for Xconomy. You can e-mail him at ltimmerman@xconomy.com, call 206-624-2374, or follow him on Twitter at http://twitter.com/ldtimmerman.